California Academy of Sciences leverages ColorWorks on-demand label printers for entomology collection organization "For ...

The 43rd National Pharmaceutical Industry Information Annual Conference and the 2026 Beijing · Changping Life Science Forum opened at Beijing Changping Future Science City on July 12. A Media Snippet ...

Conducting successful and impactful research involves time, energy, sacrifice, failure, grit, resilience, and learning on the ...

The 2026 Beijing · Changping Forum on Life Science will be held from July 11 to 12 at the Petroleum Science & Technology Communication Center in Changping District, Beijing. The forum covers multiple ...

The 74 reports on 11 AI prompts that can assist teachers in streamlining tasks and enhancing creativity, helping to improve their work-life balance and effectiveness.

Bio-Techne Corp. (NASDAQ:TECH) is one of the 9 Stocks Winning by Double Digits. Bio-Techne rallied for a third straight day on Thursday, surging 20.08 percent to close at $70.70 apiece, as investors ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the Minneapolis-based group Bio-Techne, according to a news release posted ...

Germany’s Merck MRK0.07%increase; up pointing triangle KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne TECH 0.21%increase; up pointing triangle for $11.3 billion, in an ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal represents a 36% ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade ...

German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.